AURA NASDAQ
Aura Biosciences, Inc.
1W: -8.0%
1M: -24.4%
3M: +12.6%
YTD: +19.8%
1Y: -2.3%
3Y: -47.5%
$6.33
-0.03 (-0.39%)
Weekly Expected Move ±4.4%
$6
$6
$7
$7
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026137
Institutions Holding
+13 vs prior
76.9%
Ownership
+10.35%
21
New
36
Increased
60
Reduced
23
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-19 | Holles Natalie C. | officer: see remarks | A-Grant/Award | 553,844 | $— | $0 | Filing |
| 2026-05-19 | Holles Natalie C. | officer: see remarks | A-Grant/Award | 600,118 | $— | $0 | Filing |
| 2026-04-16 | Kilroy Conor | officer: see remarks | S-Sale | 11,738 | $7.02 | $82K | Filing |
| 2026-03-02 | Kilroy Conor | officer: see remarks | A-Grant/Award | 62,339 | $— | $0 | Filing |
| 2026-03-02 | Gibney Anthony S | officer: see remarks | A-Grant/Award | 71,245 | $— | $0 | Filing |
| 2026-03-02 | de los Pinos Elisabet | officer: see remarks | A-Grant/Award | 166,000 | $— | $0 | Filing |
| 2026-03-02 | Plavsic Mark | officer: chief technology officer | A-Grant/Award | 62,339 | $— | $0 | Filing |
| 2026-03-02 | Hopkins Janet Jill | officer: chief medical officer | A-Grant/Award | 89,056 | $— | $0 | Filing |
| 2026-03-02 | Elazzouzi Amy | officer: senior vice president, finance | A-Grant/Award | 44,528 | $— | $0 | Filing |
| 2026-02-17 | Elazzouzi Amy | officer: senior vice president, finance | S-Sale | 8,549 | $5.06 | $43K | Filing |
| 2026-02-17 | de los Pinos Elisabet | officer: see remarks | S-Sale | 47,648 | $5.06 | $241K | Filing |
| 2026-02-17 | Hopkins Janet Jill | officer: chief medical officer | S-Sale | 20,401 | $5.06 | $103K | Filing |
| 2026-02-17 | Plavsic Mark | officer: chief technology officer | S-Sale | 15,890 | $5.05 | $80K | Filing |
| 2026-02-17 | Kilroy Conor | officer: see remarks | S-Sale | 12,079 | $5.05 | $61K | Filing |
| 2026-01-20 | Elazzouzi Amy | officer: senior vice president, finance | S-Sale | 1,581 | $4.86 | $8K | Filing |
| 2026-01-20 | de los Pinos Elisabet | officer: see remarks | S-Sale | 16,928 | $4.86 | $82K | Filing |
| 2025-11-17 | Hopkins Janet Jill | officer: chief medical officer | S-Sale | 17,109 | $5.42 | $93K | Filing |
| 2025-10-29 | Elazzouzi Amy | officer: senior vice president, finance | S-Sale | 896 | $6.35 | $6K | Filing |
| 2025-10-29 | de los Pinos Elisabet | officer: see remarks | S-Sale | 9,049 | $6.35 | $57K | Filing |
| 2025-10-16 | Plavsic Mark | officer: chief technology officer | S-Sale | 12,169 | $6.35 | $77K | Filing |
| 2025-08-18 | Elazzouzi Amy | officer: senior vice president, finance | S-Sale | 7,722 | $6.70 | $52K | Filing |
| 2025-06-17 | Johnson David Michael | director | A-Grant/Award | 13,000 | $— | $0 | Filing |
| 2025-06-17 | Srivastava Sapna | director | A-Grant/Award | 13,000 | $— | $0 | Filing |
| 2025-06-17 | Mattessich Antony C. | director | A-Grant/Award | 13,000 | $— | $0 | Filing |
| 2025-06-02 | Gibney Anthony S | officer: see remarks | A-Grant/Award | 150,000 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| Matrix Capital Management Company, LP | 6,922,870 | $46M | — | 2026-03-31 | Filing |
| Frazier Life Sciences Management, L.P. | 5,100,000 | $34M | — | 2026-03-31 | Filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,881,125 | $33M | — | 2026-03-31 | Filing |
| Long Focus Capital Management, LLC | 4,619,582 | $31M | — | 2026-03-31 | Filing |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,372,884 | $29M | — | 2026-03-31 | Filing |
| BlackRock, Inc. | 3,586,640 | $24M | +26,216 | 2026-03-31 | Filing |
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $20M | — | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,243,828 | $15M | +2,243,828 | 2026-03-31 | Filing |
| FRANKLIN RESOURCES INC | 2,072,726 | $14M | -125,697 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,310,862 | $9M | +55,412 | 2026-03-31 | Filing |
| STATE STREET CORP | 964,670 | $6M | +38,136 | 2026-03-31 | Filing |
| LEVIN CAPITAL STRATEGIES, L.P. | 941,400 | $6M | -94,186 | 2026-03-31 | Filing |
| B Group, Inc. | 597,576 | $4M | +25,000 | 2026-03-31 | Filing |
| ACORN CAPITAL ADVISORS, LLC | 595,744 | $4M | — | 2026-03-31 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 558,158 | $4M | +40,242 | 2026-03-31 | Filing |
| Balyasny Asset Management L.P. | 557,654 | $4M | +557,654 | 2026-03-31 | Filing |
| Regency Capital Management Inc.\DE | 532,495 | $4M | -6,089 | 2026-03-31 | Filing |
| NORTHERN TRUST CORP | 430,522 | $3M | +17,713 | 2026-03-31 | Filing |
| VANGUARD FIDUCIARY TRUST CO | 397,160 | $3M | +397,160 | 2026-03-31 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 391,334 | $3M | +391,334 | 2026-03-31 | Filing |